MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05018cam a22004334i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
14475488 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20201025094353.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
060728s2007 fluaf b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2006024885 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0849371945 (hardcover : alk. paper) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780849371943 (hardcover : alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
NLM |
| -- |
BAKER |
| -- |
C#P |
| -- |
YDX |
| -- |
YDXCP |
| -- |
DLC |
| Description conventions |
rda |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC262 |
| Item number |
.N22 2007 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| Edition number |
22 |
| Item number |
N |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Nanotechnology for cancer therapy / |
| Statement of responsibility, etc |
edited by Mansoor M. Amiji. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Boca Raton : |
| Name of publisher, distributor, etc |
CRC/Taylor & Francis, |
| Date of publication, distribution, etc |
[2007] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
©2007 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
817 pages, [8] pages of plates : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
27 cm |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Source |
rdacarrier |
| Carrier type term |
volume |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section I. Nanotechnology and Cancer -- Chapter 1. Introduction and Rationale for Nanotechnology in Cancer Therapy. -- Chapter 2. Passive Targeting of Solid Tumors: Pathophysiological Principles and Physicochemical Aspects of Delivery Systems. -- Chapter 3. Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications -- Chapter 4. Pharmacokinetic Analysis of Nanocarrier-Mediated Drug and Gene Delivery. -- Chapter 5. Multifunctional Nanoparticles for Cancer Therapy. Chapter 6. Neutron Capture Therapy of Cancer: Nanoparticles and High Molecular Weight Boron Delivery Agents. -- Chapter 7. Preclinical Characterization of Engineered Nanoparticles Intended for Cancer Therapeutics.-- Chapter 8. Nanotechnology: Regulatory Perspective for Drug Development in Cancer Therapeutics. -- Section II. Polymer Conjugates -- Chapter 9. Polymeric Conjugates for Angiogenesis Targeted Tumor Imaging and Therapy. -- Chapter 10. Poly(L-glutamic acid): Efficient Carrier of Cancer Therapeutics and Diagnostics. -- Chapter 11. Non-Invasive Visualization of In Vivo Drug Delivery of Paramagnetic Polymer Conjugates with MRI .-- Section III. Polymeric Nanoparticles -- Chapter 12. Polymeric Nanoparticles for Tumor-Targeted Drug Delivery. -- Chapter 13. Long-circulating Polymeric Nanocarriers for Drug and Gene Delivery to Tumors -- Chapter 14. Biodegradable PLGA/PLA Nanoparticles for Anticancer Therapy. -- Chapter 15. Poly(alkyl cyanoacrylate) Nanoparticles for Delivery of Anticancer Drugs. -- Chapter 16. Aptamers and Cancer Nanotechnology. -- Section IV. Polymeric Micelles -- Chapter 17. Polymeric Micelles for Formulation of Anticancer Drugs. -- Chapter 18. PEO-Modified Poly(L-amino acid) Micelles for Drug Delivery. -- Chapter 19. Hydrotropic Polymer Micellar for Cancer Therapeutics. -- Chapter 20. Tumor-targeted delivery of sparingly-soluble anticancer drugs with polymeric lipid-core immunomicelles. -- Chapter 21. Combined Cancer Therapy by Micellar-Encapsulated Drug and Ultrasound. -- Chapter 22. Polymeric Micelles for Targeting Tumor pH. -- Chapter 23. cRGD-Encoded, MRI-Visible Polymeric Micelles for Tumor-Targeted Drug Delivery. -- Chapter 24. Targeted Antisense Oligonucleotide Micellar Delivery Systems. -- Section V. Dendritic Nanocarriers -- Chapter 25. Dendrimers in Drug and Gene Delivery. -- Chapter 26. Dendritic Nanostructures for Cancer Therapy. -- Chapter 27. PEGylated Dendritic Nanoparticulate Carriers of Anticancer Drug. -- Chapter 28. Dendrimer Nanocomposites for Cancer Therapy. -- Section VI. Liposomes -- Chapter 29. Applications of Liposomal Drug Delivery Systems to Cancer Therapy. -- Chapter 30. Positively-Charged Liposomes for Targeting Tumor <br/>-- Chapter 31. Cell Penetrating Peptide (CPP)-Modified Liposomal Nanocarriers for Intracellular Drug and Gene Delivery. -- Chapter 32. RGD-Modified Liposomes for Tumor Targeting. S.P. Vyas -- Chapter 33. Folate Receptor-Targeted Liposomes for Cancer Therapy. -- Chapter 34. Nanoscale Drug Delivery Vehicles for Solid Tumors: A New Paradigm for Localized Drug Delivery Using Temperature Sensitive Liposomes. -- Section VII. Other Lipid Nanostructures -- Chapter 35. Nanoemulsions for Tumor Targeted Delivery. -- Chapter 36. Solid-Lipid Nanoparticles for Antitumor Drug Delivery. -- Chapter 37. Lipoprotein Nanoparticles as Delivery Vehicles for Anti-cancer Therapy. -- Chapter 38. DQAsomes as Mitochondria-Targeted Nano-Carriers for Anticancer Drugs. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nanotechnology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug targeting. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic agents. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
therapy. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Delivery Systems. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nanotechnology. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neoplasms |
| General subdivision |
diagnosis. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Amiji, Mansoor M. |
| Relator term |
editor. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents only |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/ecip0618/2006024885.html">http://www.loc.gov/catdir/toc/ecip0618/2006024885.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0664/2006024885-d.html">http://www.loc.gov/catdir/enhancements/fy0664/2006024885-d.html</a> |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1667">http://repository.fue.edu.eg/xmlui/handle/123456789/1667</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Books |
| Source of classification or shelving scheme |
Dewey Decimal Classification |